BIIB014 Cardiovascular Monitoring Study

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The study will examine the effects of a single dose of BIIB014 on blood pressure and haemodynamic variables in healthy volunteers over 24 hours.

Key facts

Study ID

NCT01035515

Run by

Biogen

People needed

24

Starts

2009-12-01

Expected to finish

2010-04-01

Last updated by the study team

2010-06-22

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or female subjects
• Between the ages of 18 and 50, inclusive.
• Must have a body mass index (BMI) between 19 kg/m2 and 30 kg/m2, inclusive

You may not qualify if…

• Clinically significant abnormalities (as determined by the Investigator)
• Other unspecified reason that would make the subject unsuitable for enrollment (as determined by the Investigator)

Where it is running

• Quintiles Inc — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.